University of Calgary
University of Calgary
Calgary, Alberta, Canada17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pridopidine Phase 3 Study in Huntington's Disease | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder | Recruiting | Phase 3 | 2026-10-07 | NCT07609108 | |
| Cannabis (THC vs. CBD) in Multiple Sclerosis | CNS demyelinating autoimmune disease, Chemically-Induced Disorders, autoimmune disease, autoimmune disorder of the nervous system, cannabis dependence, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-09-15 | NCT06261489 | |
| A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study | Mycobacterium Avium Complex Pulmonary Disease | Recruiting | Not stated | 2026-09-15 | NCT05906316 | |
| COgnitioN With VERiciGuat Evaluation in Heart Failure | Cognition Disorders, Cognitive Dysfunction, cardiovascular disorder, cognitive disorder, heart disorder, heart failure, psychiatric disorder | Recruiting | Phase 2 | 2026-08-25 | NCT06601465 | |
| On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study | Thrombotic and Bleeding Events | Active, not recruiting | Not stated | 2026-07-14 | NCT02677974 | |
| Predictors of Relapse in Major Depressive Disorder (PERFORM-D) | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Not stated | 2026-07-10 | NCT06746155 | |
| MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation | Cardiac Allograft Vasculopathy | Recruiting | Not applicable | 2026-05-06 | NCT06089486 | |
| CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study | autonomic nervous system disorder, nervous system disorder, primary dysautonomia, pure autonomic failure | Recruiting | Not applicable | 2026-05-05 | NCT05908760 | |
| Hypercapnia in Orthostatic Hypotension | Hypotension, Orthostatic, autonomic nervous system disorder, cardiovascular disorder, hypotensive disorder, nervous system disorder, orthostatic intolerance, primary dysautonomia, vascular disorder | Recruiting | Not applicable | 2026-05-05 | NCT05295810 | |
| Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not applicable | 2026-04-29 | NCT03035851 | |
| Belimumab in Autoimmune Hepatitis | Digestive System Diseases, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, hepatitis, immune system disorder, liver disorder | Recruiting | Phase 2 | 2026-04-24 | NCT06381453 | |
| A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). | Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-19 | NCT05608681 | |
| Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial | Pathological Conditions, Signs and Symptoms, Personality Disorders, Prodromal Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, psychiatric disorder, schizotypal personality disorder | Active, not recruiting | Not applicable | 2026-01-26 | NCT04338152 | |
| Pharmacogenomics of Stimulant Treatment Response | attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder | Recruiting | Not stated | 2025-12-05 | NCT06221358 | |
| Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD | Arterial Occlusive Diseases, Intracranial Atherosclerosis, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, vascular disorder | Recruiting | Not applicable | 2025-11-20 | NCT06714526 | |
| AMP SCZ® Observational Study: PREDICT-DPACC | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder | Active, not recruiting | Not stated | 2025-10-31 | NCT05905003 | |
| PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 4 | 2025-06-11 | NCT05928039 |